tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

AUTL Stock Latest News

Abstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL selected for an oral presentation at ASCO
Press ReleasesAbstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL selected for an oral presentation at ASCO
2d ago
AUTL
Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
PremiumPress Releases
Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
3d ago
AUTL
Autolus Therapeutics price target raised to $11 from $10 at Truist
PremiumThe Fly
Autolus Therapeutics price target raised to $11 from $10 at Truist
17d ago
AUTL
Autolus Therapeutics announces acceptance of MAA by EMA for obe-cel
PremiumThe Fly
Autolus Therapeutics announces acceptance of MAA by EMA for obe-cel
24d ago
AUTL
Autolus Therapeutics Announces Board Leadership Changes
PremiumCompany Announcements
Autolus Therapeutics Announces Board Leadership Changes
25d ago
8K
AUTL
Autolus chairman John Johnson steps down, Mike Bonney succeeds
PremiumThe FlyAutolus chairman John Johnson steps down, Mike Bonney succeeds
25d ago
AUTL
Autolus Therapeutics Announces Changes to its Board of Directors
PremiumPress Releases
Autolus Therapeutics Announces Changes to its Board of Directors
25d ago
AUTL
Autolus files to sell 33.33M American Depositary Shares for holders
PremiumThe Fly
Autolus files to sell 33.33M American Depositary Shares for holders
29d ago
AUTL
Aveo Oncology appoints Edgar Braendle as CMO
PremiumThe Fly
Aveo Oncology appoints Edgar Braendle as CMO
1M ago
AUTL
Autolus Therapeutics price target raised to $10 from $9 at Truist
PremiumThe Fly
Autolus Therapeutics price target raised to $10 from $9 at Truist
1M ago
AUTL
BNTX
Autolus Therapeutics Announces Annual Results and CDO Resignation
PremiumCompany Announcements
Autolus Therapeutics Announces Annual Results and CDO Resignation
1M ago
8K
AUTL
Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
PremiumPress Releases
Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
1M ago
AUTL
Autolus Therapeutics says ‘well capitalized’ for pipeline development plans
PremiumThe FlyAutolus Therapeutics says ‘well capitalized’ for pipeline development plans
1M ago
AUTL
Autolus Therapeutics reports 2023 EPS ($1.20), consensus ($1.01)
PremiumThe Fly
Autolus Therapeutics reports 2023 EPS ($1.20), consensus ($1.01)
1M ago
AUTL
Autolus Therapeutics receives MHRA certification for Nucleus site
PremiumThe Fly
Autolus Therapeutics receives MHRA certification for Nucleus site
2M ago
AUTL
Autolus Therapeutics receives Medicines and Healthcare products Regulatory Agency (MHRA) certification for Nucleus commercial manufacturing site
PremiumPress Releases
Autolus Therapeutics receives Medicines and Healthcare products Regulatory Agency (MHRA) certification for Nucleus commercial manufacturing site
2M ago
AUTL
AUTL Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
AUTL Upcoming Earnings Report: What to Expect?
2M ago
AUTL
Autolus Therapeutics announces publication in Blood Cancer Journal
PremiumThe Fly
Autolus Therapeutics announces publication in Blood Cancer Journal
2M ago
AUTL
Autolus Therapeutics to Report Full Year 2023 Financial Results and Business Updates on March 14, 2024
PremiumPress Releases
Autolus Therapeutics to Report Full Year 2023 Financial Results and Business Updates on March 14, 2024
2M ago
AUTL
Autolus Therapeutics announces publication in Nature Communications
PremiumThe FlyAutolus Therapeutics announces publication in Nature Communications
2M ago
AUTL
Autolus Therapeutics Shares Updated Corporate Insights
PremiumCompany Announcements
Autolus Therapeutics Shares Updated Corporate Insights
2M ago
8K
AUTL
Autolus Therapeutics Announces New Offering Expectations
PremiumCompany Announcements
Autolus Therapeutics Announces New Offering Expectations
3M ago
8K
AUTL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >